Testing effectiveness (Phase 2)Study completedNCT05004181
What this trial is testing
Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants
Who this might be right for
SARS-CoV-2 InfectionCOVID-19SARS-CoV-2 Acute Respiratory Disease+1 more
BioNTech SE 1,380